Supha Pharmachem LtdBSE: SUPHA

Remedium Lifecare - Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On August 09, 2024 Pursuant To Reg 30 (Read With Part A Of Schedule III) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio

· Issued by Supha Pharmachem Ltd via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/remedium-lifecare-board-meeting-outcome-for-board-meeting-outcome-for-outcome-of-the-board-meeting-held-on-august-09-2024-pursuant-to-reg-30-read-with-part-a-of-schedule-iii-of-the-sebi-listing-obligations-and-disclosure-requirements-regulatio

In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their meeting held today on 31st October 2024 at the Registered Office of the Company at 1.00 P.M

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Supha Pharmachem Ltd on 6ix

Later from Supha Pharmachem

All Supha Pharmachem news releases